Longeveron

LGVNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$24.204 M

$0.77 -0.97%

Close of 7 Aug 2026

Revenue

$1.20M

#3490 by revenue

Earnings

-$22.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#385IGC PharmaIGC$24.6M
#386Barinthus BiotherapeuticsBRNS$24.5M
#387LongeveronLGVN$24.2M
#388TherapeuticsMDTXMD$24.0M
#389Tvardi TherapeuticsTVRD$23.3M

Where these numbers come from

Share counts and financials for Longeveron are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.